SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-039900
Filing Date
2023-11-08
Accepted
2023-11-08 16:05:29
Documents
35
Period of Report
2023-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40177
2 ex99-1.htm EX-99.1 66887
3 ex99-2.htm EX-99.2 21092
4 ex99-2_001.jpg GRAPHIC 168646
5 ex99-2_002.jpg GRAPHIC 774098
6 ex99-2_003.jpg GRAPHIC 279901
7 ex99-2_004.jpg GRAPHIC 398656
8 ex99-2_005.jpg GRAPHIC 329765
9 ex99-2_006.jpg GRAPHIC 294076
10 ex99-2_007.jpg GRAPHIC 285666
11 ex99-2_008.jpg GRAPHIC 357833
12 ex99-2_009.jpg GRAPHIC 398161
13 ex99-2_010.jpg GRAPHIC 391163
14 ex99-2_011.jpg GRAPHIC 389938
15 ex99-2_012.jpg GRAPHIC 294405
16 ex99-2_013.jpg GRAPHIC 392717
17 ex99-2_014.jpg GRAPHIC 372156
18 ex99-2_015.jpg GRAPHIC 449116
19 ex99-2_016.jpg GRAPHIC 432342
20 ex99-2_017.jpg GRAPHIC 84943
21 ex99-2_018.jpg GRAPHIC 366662
22 ex99-2_019.jpg GRAPHIC 353044
23 ex99-2_020.jpg GRAPHIC 166337
24 ex99-1_001.jpg GRAPHIC 5721
  Complete submission text file 0001493152-23-039900.txt   9941234

Data Files

Seq Description Document Type Size
25 XBRL SCHEMA FILE ltrn-20231108.xsd EX-101.SCH 3030
26 XBRL LABEL FILE ltrn-20231108_lab.xml EX-101.LAB 34240
27 XBRL PRESENTATION FILE ltrn-20231108_pre.xml EX-101.PRE 22369
29 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3409
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39318 | Film No.: 231387762
SIC: 2834 Pharmaceutical Preparations